Riverside, United States. 23rd Dec, 2021. Signage outside of the Merck Cherokee Plant in Riverside, Pennsylvania on December, 23, 2021. The U.S. Food and Drug Administration (FDA) issued an emergency use authorization for Merck's molnupiravir for the treatment of mild-to-moderate coronavirus disease (COVID-19) in adults who are at high risk for progression to severe COVID-19. (Photo by Paul Weaver/Sipa USA) Credit: Sipa USA/Alamy Live News

Riverside, United States. 23rd Dec, 2021. Signage outside of the Merck Cherokee Plant in Riverside, Pennsylvania on December, 23, 2021. The U.S. Food and Drug Administration (FDA) issued an emergency use authorization for Merck's molnupiravir for the treatment of mild-to-moderate coronavirus disease (COVID-19) in adults who are at high risk for progression to severe COVID-19. (Photo by Paul Weaver/Sipa USA) Credit: Sipa USA/Alamy Live News Stock Photo
Preview

Image details

Contributor:

Sipa USA / Alamy Stock Photo

Image ID:

2HC2XKR

File size:

34.5 MB (4 MB Compressed download)

Releases:

Model - no | Property - noDo I need a release?

Dimensions:

4251 x 2834 px | 36 x 24 cm | 14.2 x 9.4 inches | 300dpi

Date taken:

23 December 2021

Photographer:

Sipa USA

More information:

This image could have imperfections as it’s either historical or reportage.

Available for Editorial use only.